New Leaf Venture Partners, L.L.C. Neuronetics, Inc. Transaction History

New Leaf Venture Partners, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$1.82 - $5.87 $983,376 - $3.17 Million	-540,317 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.41 - $2.61 $361,478 - $669,120	-256,368 Reduced 32.18%	540,317 $1.04 Million
Q1 2020 May 14, 2020	SELL	$1.28 - $4.5 $310,528 - $1.09 Million	-242,600 Reduced 23.34%	796,685 $1.51 Million
Q4 2019 Feb 13, 2020	SELL	$4.03 - $9.22 $1.36 Million - $3.1 Million	-336,721 Reduced 24.47%	1,039,285 $4.67 Million
Q3 2019 Nov 14, 2019	SELL	$8.31 - $13.03 $1.39 Million - $2.18 Million	-167,109 Reduced 10.83%	1,376,006 $11.4 Million

Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $41.1 Million - $42.9 Million	1,543,115 New	1,543,115 $41.1 Million

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $49.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.